American Association for the Advancement of Science, Science Immunology, 61(6), 2021
DOI: 10.1126/sciimmunol.abe9950
Full text: Unavailable
Cross-reactive antibodies present after SARS-CoV-2 infection can distinguish patients with COVID-19 from uninfected individuals.